Browsing by Author "Petrakova, K."
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
Item nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2-advanced breast cancer(2019) Hamiton, E.; Cortes, J.; Dieras, V.; Ozyilkan, O.; Chen, S-C.; Petrakova, K.; Manikhas, A.; Jerusalem, G.; Hegg, R.; Lu, Y.; Bear, M.M.; Johnston, E.L.; Martin, M.Item nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, HER2-metastatic breast cancer(2020) Hamilton, E.P.; Cortes, J.; Ozyilkan, O.; Chen, S-C.; Petrakova, K.; Manikhas, A.; Jerusalem, G.; Hegg, R.; Huober, J.; Chapman, S.C.; Yang, Z.; Chen, Y.; Johnston, E.L.; Martin, M.; 0000-0001-8825-4918; AAD-2817-2021Item nextMONARCH: Final overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with HR+, Her2-metastatic breast cancer(2021) Huober, J.; Hamilton, E.; Cortes, J.; Ozyilkan, O.; Chen, S.C.; Petrakova, K.; Manikhas, A.; Jerusalem, G.; Hegg, R.; Chapman, S.; Yang, Z.; Chen, Y.; Johnston, E.; Martin, M.